Abstract:Background: The interpretation system for prostate MRI is largely based on qualitative image contrast of different tissue types. Therefore, a fast, standardized, and robust quantitative technique is necessary. Synthetic MRI is capable of quantifying multiple relaxation parameters, which might have potential applications in prostate cancer (PCa). Purpose: To investigate the use of quantitative relaxation maps derived from synthetic MRI for the diagnosis and grading of PCa. Study type: Prospective. Subjects: In all, 94 men with pathologically confirmed PCa or benign pathological changes. Field strength/sequence: T1 -weighted imaging, T2 -weighted imaging, diffusion-weighted imaging, and synthetic MRI at 3.0T. Assessment: Four kinds of tissue types were identified on pathology, including PCa, stromal hyperplasia (SH), glandular hyperplasia (GH), and noncancerous peripheral zone (PZ). PCa foci were grouped as low-grade (LG, Gleason score ≤6) and intermediate/high-grade (HG, Gleason score ≥7). Regions of interest were manually drawn by two radiologists in consensus on parametric maps according to the pathological results. Statistical tests: Independent sample t-test, Mann-Whitney U-test, and receiver operating characteristic curve analysis. Results: T1 and T2 values of PCa were significantly lower than SH (P = 0.015 and 0.002). The differences of T1 and T2 values between PCa and noncancerous PZ were also significant (P ≤ 0.006). The area under the curve (AUC) of the apparent diffusion coefficient (ADC) value was significantly higher than T1 , T2 , and proton density (PD) values in discriminating PCa from SH and noncancerous PZ (P ≤ 0.025). T2 , PD, and ADC values demonstrated similar diagnostic performance in discriminating LG from HG PCa (AUC = 0.806 [0.640-0.918], 0.717 [0.542-0.854], and 0.817 [0.652-0.925], respectively; P ≥ 0.535). Data conclusion: Relaxation maps derived from synthetic MRI were helpful for discriminating PCa from other benign pathologies. But the overall diagnostic performance was inferior to the ADC values. T2 , PD, and ADC values performed similarly in discriminating LG from HG PCa lesions. Level of evidence: 2 Technical Efficacy Stage: 2 J. Magn. Reson. Imaging 2020;52:552-564.

Functional Magnetic Resonance Imaging in Prostate Cancer

Application and Progress of Magnetic Resonance Imaging in Diagnosis of Pediatric Tumors

Real-time precision targeted prostate biopsy using transrectal ultrasound-magnetic resonance fusion

Magnetic Resonance Imaging for Detecting Prostate Cancer

Computer-aided Detection of Prostate Cancer with MRI: Technology and Applications.

Rectal Cancer Magnetic Resonance Imaging: Imaging Beyond Morphology

The progress of diffusion-weighted MRI application in prostate cancer diagnosis

The Application of Function Magnetic Resonance Imaging in the Diagnosis and Treatment of Breast Cancer

Magnetic resonance spectroscopic imaging: current status in the management of prostate cancer

Quantification of Multi-Parametric Magnetic Resonance Imaging Based on Radiomics Analysis for Differentiation of Benign and Malignant Lesions of Prostate

[Advances in artificial intelligence-assisted MRI radiomics in the diagnosis and treatment of prostate cancer]

MRI Diagnosis of Prostate Cancer and the Influence Factors

The Applied Research of Simultaneous Image Acquisition of T2-weighted Imaging (T2WI) and Diffusion-Weighted Imaging (DWI) in the Assessment of Patients with Prostate Cancer.

A Meta Analysis for Local Staging of Prostate Cancer Using Magnetic Resonance Imaging

The Value of Magnetic Resonance Imaging in the Detection of Prostate Cancer in Patients with Previous Negative Biopsies and Elevated Prostate-specific Antigen Levels: A Meta-analysis

Magnetic Resonance Imaging - Ultrasound Fusion Targeted Biopsy Outperforms Standard Approaches in Detecting Prostate Cancer: A Meta-Analysis.

Functional magnetic resonance imaging in oncology: state of the art

Usefulness of Diffusion-weighted Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer

What benefit can be obtained from magnetic resonance imaging diagnosis with artificial intelligence in prostate cancer compared with clinical assessments?

Diagnosis and Grading of Prostate Cancer by Relaxation Maps From Synthetic MRI

Amide Proton Transfer-weighted MRI combined with serum prostate-specific antigen levels for differentiating malignant prostate lesions from benign prostate lesions: a retrospective cohort study